Trial intelligence / Profile preview

In-vitro Effects of Vasopressors on Human Myometrium and Umbilical Vessels

NCT04053478Recruiting

Sponsor
Mount Sinai Hospital
Start
Jul 2019
Primary completion
Dec 2026
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Trial of ephedrine, phenylephrine, norepinephrine and vasopressin in hypotension (12 arms), sponsored by Mount Sinai Hospital. Primary endpoint: Motility index at 4 hours. Started Jul 2019; status: recruiting.

02

Drugs

ephedrinephenylephrinenorepinephrinevasopressin
03

Conditions

hypotension

Beyond the preview

Go deeper on NCT04053478.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04053478.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call